Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1859439Generated: October 30, 2026

(R)-5-[1-(4-chlorophenethyl)piperidine-2-ylmethyl]-5,11-dihydro-dibenzo[b,e][1,4]oxazepine → (R)-5-[1-(4-chlorophenethyl)piperidine-2-ylmethyl]-5,11-dihydrodibenzo [b,e][1,4]oxazepine Hydrochloride

https://huagongshe.com/reaction/1859439

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(R)-5-[1-(4-chlorophenethyl)piperidine-2-ylmethyl]-5,11-dihydro-dibenzo[b,e][1,4]oxazepineHCID 12018619—
ReactantHydrogen chloride-ethyl acetateHCID 21866389—
SolventDichloromethaneHCID 6344—
Product(R)-5-[1-(4-chlorophenethyl)piperidine-2-ylmethyl]-5,11-dihydrodibenzo [b,e][1,4]oxazepine HydrochlorideHCID 69900813—

Reaction Steps

1.5 ml of 4 M hydrochloric acid/ethyl acetate was added to a solution of (R)-5-[1-(4-chlorophenethyl)piperidine-2-ylmethyl]-5,11-dihydrodibenzo[b,e][1,4]oxazepine (160 mg) in dichloromethane (5 ml), and they were stirred for 2 hours. The solvent was evaporated under reduced pressure. The title compound was obtained in the form of a white solid (155 mg, 87%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06528504B2
Source datasetuspto-grants-2003_03
ORD IDord-b0d1b6d5144c4e90bd2a9559034279b7
Source noteuspto-grants-2003_03